4 results
To test the clinical efficacy of vibrating socks, a new tactile cueing device, for the management of FOG in patients with PD.
Objectives: 1. The primary objective is to evaluate the safety and immune modulation of TIL plus IFN* in epithelial ovarian cancer (EOC) patients and to determine the optimal dose of IFN* that can be given in combination with chemotherapy.2.…
To evaluate the usability of vibrating socks as a home-based tactile cueing device in PD.
Primary Objective: To evaluate the long-term safety (including progression to acute myeloid leukemia (AML) and/or other malignancies/pre-malignancies) of luspatercept in subjects who have participated in other luspatercept clinical trials.Secondary…